ScholarGate
Assistent

Recipient Evaluation and Candidacy Assessment

Recipient evaluation is the structured, multidisciplinary process by which a transplant program decides whether a patient with end-stage organ failure should be listed for transplantation. It weighs the anticipated survival and quality-of-life benefit of a transplant against the surgical risk, the burden of comorbidity, the ability to tolerate lifelong immunosuppression, and psychosocial and adherence factors. The output is a candidacy decision: list, defer pending further work-up, or decline.

Hitta ämne med PaperMindSnartFind papers & topics
Tools & resources
Ladda ner bildspel
Learn & explore
VideoSnart

Definition

Recipient evaluation and candidacy assessment is the comprehensive evaluation that determines whether a patient is a suitable candidate for organ transplantation, integrating medical, surgical, immunologic, infectious, and psychosocial findings into a listing decision.

Scope

This topic covers the components and logic of candidacy assessment for solid-organ transplantation: medical and surgical evaluation, identification of absolute and relative contraindications, immunologic and infectious considerations, and psychosocial assessment. It does not cover the specific cardiovascular work-up (a separate topic), the detailed laboratory and screening panels (a separate topic), or post-transplant care. It is a reference overview, not a listing protocol.

Core questions

  • Will the patient gain meaningful survival or quality-of-life benefit from transplantation relative to remaining on supportive therapy?
  • Are there absolute contraindications, such as active untreated malignancy or uncontrolled infection?
  • Can the patient safely undergo the operation and tolerate lifelong immunosuppression?
  • Do psychosocial, adherence, or support factors affect the likelihood of a good outcome?
  • What reversible barriers should be addressed before listing?

Key concepts

  • Risk-benefit assessment
  • Absolute contraindications
  • Relative contraindications
  • Multidisciplinary transplant evaluation
  • Psychosocial and adherence assessment
  • Immunologic sensitization
  • Active malignancy and infection exclusion
  • Listing and waitlisting decision

Clinical relevance

Candidacy assessment governs access to transplantation and influences both individual outcomes and the stewardship of scarce donor organs. Guidelines such as the KDIGO candidate guideline describe the domains a program typically evaluates and the conditions generally considered contraindications. This topic explains how evaluation is structured and is not a basis for deciding an individual patient's eligibility.

Epidemiology

Registry reports such as the OPTN/SRTR annual data report describe waitlist size, candidate characteristics, and the gap between candidates and available organs, which is part of why candidacy evaluation is rigorous. Comorbidity burden among candidates with end-stage organ failure is high, shaping the breadth of the evaluation.

Evidence & guidelines

The 2020 KDIGO guideline on evaluation and management of kidney transplant candidates is a widely referenced framework for candidacy domains and contraindications. Registry data (OPTN/SRTR) describe candidate and waitlist epidemiology, and reviews of transplant infection inform the infectious component of evaluation.

Debates

How should psychosocial factors influence listing?
Programs weigh adherence history, social support, and substance use as predictors of outcome, but the appropriate weight and the risk of inequitable exclusion remain debated within candidacy assessment.

Related topics

Seminal works

  • chadban-2020
  • hart-2021

Frequently asked questions

What is the goal of recipient candidacy assessment?
To determine whether a patient is likely to benefit from and tolerate transplantation, by systematically evaluating medical, surgical, immunologic, infectious, and psychosocial factors before listing.
What are common contraindications identified during evaluation?
Conditions such as active untreated malignancy, uncontrolled active infection, or comorbidity that makes the operation or lifelong immunosuppression unsafe are generally treated as contraindications, though specifics vary by organ and program.

Methods for this concept

Related concepts